Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
TOKYO–(BUSINESS WIRE)–$INCY–Incyte Biosciences Japan G.K. today announced approval from Japan’s Ministry of Health, Labour and Welfare (MHLW)... Read more.
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
TOKYO–(BUSINESS WIRE)–$INCY–Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz®... Read more.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–The first patient has been dosed in the DESTINY-Endometrial02 phase 3 trial evaluating ENHERTU® (trastuzumab... Read more.
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published
ROME–(BUSINESS WIRE)–Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”)... Read more.
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
Tenth Breakthrough Therapy Designation for Daiichi Sankyo and AstraZeneca’s ENHERTU with the latest based on DESTINY-Breast05 phase 3 trial results Sixteenth Breakthrough... Read more.
Coty Appoints Markus Strobel Executive Chairman and Interim CEO
NEW YORK–(BUSINESS WIRE)–Regulatory News: Coty Inc. (NYSE: COTY) (Paris: COTY) (“Coty” or “the Company”) today announced that Markus Strobel... Read more.
JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group’s Life and Pensions Business
MIAMI–(BUSINESS WIRE)–JAB Insurance today announced that it has entered into a definitive agreement to acquire from Utmost Group plc its Life and Pensions... Read more.
Cloudfresh Wins 2025 EMEA GitLab Partner of the Year Award for Emerging Markets in Eastern Europe and Israel
PRAGUE–(BUSINESS WIRE)–#Cloudfresh–Cloudfresh, a certified GitLab Select and Professional Services Partner and a global leader in delivering multi-vendor... Read more.
Mitsubishi Electric Invests in Tulip Interfaces And Signs Strategic Alliance Agreement
Will leverage no-code operations platform to strengthen DX solutions for manufacturing and beyond TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation... Read more.
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and... Read more.